4//SEC Filing
DAVE KAUSHIK J 4
Accession 0001181431-13-030732
CIK 0001016169other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:45 PM ET
Size
9.2 KB
Accession
0001181431-13-030732
Insider Transaction Report
Form 4
DAVE KAUSHIK J
Executive Vice President
Transactions
- Award
Common Stock
2013-05-22+29,461→ 265,028 total - Award
Common Stock
2013-05-22+29,461→ 235,567 total - Award
Stock Option (right to buy)
2013-05-22+52,083→ 695,195 totalExercise: $3.96Exp: 2023-05-21→ Common Stock (52,083 underlying)
Footnotes (5)
- [F1]Represents the target number of shares Dr. Dave may receive pursuant to the terms of the performance stock unit award made to Dr. Dave under the 2008 Equity Compensation Plan if certain performance goals are attained over the performance period specified in the award agreement evidencing the performance stock unit award and Dr. Dave continues in employment with the Company through that period.
- [F2]Not applicable
- [F3]Represents grant of shares of restricted Common Stock issued under the 2008 Equity Compensation Plan. The shares vest in three equal annual installments.
- [F4]Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F5]The options vest in equal quarterly installments over three years.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001522751
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:45 PM ET
- Size
- 9.2 KB